Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1323099 (sympathomimetic)
 2,957 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In the clinical treatment of imminent premature birth, sympathomimetic amines have greatly increased in importance as an interruptor of labor pains. The purpose of this report is to discuss the clinical findings on the basis of 30 newborns admitted to our hospital (between April 1977 and June 1978) after long-term treatment of the mother and Fenoterol (Partusisten). The predominant clinical findings were: tachycardia, paroxysmal dyspnea, cyanosis, metabolic acidosis, congestive heart failure and, in the ECG, cardiac arrhythmias and T-wave inversions in the left precordial chest leads. A high correlation was found between the clinical degree of alteration and changes in both the ECG and the VCG. In all patients these changes have normalized within 8 weeks. The histological findings of 3 deceased newborns revealed typical although not specific features such as: polyploid cells especially in the subendocardial region and a streamlined fatty degeneration of the myocardium. These findings, however, cannot prove with certainty the cardiotoxic effect of Fenoterol on the myocardium, but it appears possible that an especially high dosage of Fenoterol given i. v. can cause myocardial complications. Our findings suggest that catecholamin derivates should be applicated only with extreme caution.
 ...
PMID:[Newborn cardiotoxicity after tocolysis with fenoterolhydrobromide]. 53 Jul 23

Life-threatening asthma may be judged to be present in patients who, in the presence of a low FEV(1) are too dyspneic to speak, have altered consciousness or unequivocal cyanosis. Other physical signs which indicate airway obstruction of grave severity are pulsus paradoxus, gross thoracic overinflation and electrocardiographic evidence of pulmonary hypertension. A rise in the arterial CO(2) tension, the presence of pneumothorax or pneumomediastinum, and an FEV(1) less than 1 litre and vital capacity less than 0.5 litre, failing to increase immediately after inhalation of a bronchodilator, are also features which demand urgent and intensive therapy.Corticosteroids in large doses should be administered whenever a life-threatening situation is recognized. Systemic steroids should be stopped only when the danger phase, as indicated by the criteria given above, has been reversed. At all stages of therapy regular inhalations of a sympathomimetic bronchodilator should be maintained. Oral steroid therapy should be continued until maximum ventilatory function has been attained; only then should dose reduction be attempted.
 ...
PMID:Symposium on allergic lung disease. I. The clinical picture of asthma. 483 81

Raynaud's phenomenon is a clinical disease characterized by episodic attacks of vasoconstriction of the arteries and arterioles of the extremities such as fingers and toes, sometimes the ears and nose, in response to cold or emotional stimuli. A classic attack is the pallor of the distal extremity, followed by cyanosis and redness, accompanied by paresthesia, usually as heat. When it occurs without apparent cause is called primary Raynaud's phenomenon. When associated with other disease, is called secondary Raynaud's phenomenon. The secondary table is associated with increased frequency of rheumatic diseases of collagen. They can also present certain drugs that cause vasoconstriction, such as ergotamine, beta-adrenergic antagonists, contraception and sympathomimetic drugs. Regarding the latter, we present a case of Raynaud's phenomenon secondary to methylphenidate in a 14 years.
 ...
PMID:[Methylphenidate and secondary Raynaud's phenomenon]. 2403 62